Microfluidic Market to Actively Foray into
Emerging Consumer Marketplaces During 2018-
2026
Microfluidic devices enables the precise processing of micro liter (~0.01-10 µl) samples and
allows to perform significant biological or chemical processing such as sampling, pre-processing
and measurement involved in an assay within a single chip. Microfluidics aids in handling and
examining very small fluid volumes, around micro- (10 -6 ) to atto- (10 -18 ) liter volumes of fluid,
which provides several analytical and economic advantages over the conventional assays.
Microfluidic devices typically requires 10x times less sample volume, thereby allowing less
sample and reagent consumption. Microfluidic devices transfers such small amount of fluid
volume through microfluidic channels, which provides higher surface area to volume ratio,
which further enhance the heat transfer. Increasing advancements in microfluidics such as lab-
on-a-chip device for DNA amplification, purification, separation and sequencing, and single cell
gene-expression profiling is expected to aid in growth of the market. Microfluidic provides
enhanced analytical sensitivity, enhanced temperature control, faster reaction time, cost
efficiency and allows integration of lab routines in a single device.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1086
The global microfluidic market was valued at US$ 2.8 billion in 2016 and is expected to
witness a robust CAGR of 19.4% over the forecast period (2017–2025).
Market Dynamics:
Major factors influencing growth of the microfluidic market is rising demand for point-of-care
(POC) testing and advancements in microfluidic technology to reduce cost of sample analysis
and enabling higher efficiency. Moreover, increasing demand for home healthcare to address
growing prevalence of diabetes is supporting to growth of the microfluidic market. For instance,
in 2017 researchers at the Ewha Womens University developed an endocrine system on chip,